LEUKEMIA,MYELOID, CHRONIC
Clinical trials for LEUKEMIA,MYELOID, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA,MYELOID, CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA,MYELOID, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CML drug combo strategy aims for deeper remission without lifelong side effects
Disease control Recruiting nowThis study tests a new drug, asciminib, as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug alone does not achieve a deep response within 2 to 3 years, a low dose of another targeted therapy is added. The goal is to see if this appro…
Matched conditions: LEUKEMIA,MYELOID, CHRONIC
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill shows promise for leukemia patients who've run out of options
Disease control Recruiting nowThis study tests an oral drug called HQP1351 in people with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has not responded to at least two other treatments. The goal is to find the right dose and see how safe and effective the drug is. A…
Matched conditions: LEUKEMIA,MYELOID, CHRONIC
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC